EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends and Disparities in the Burden of Chronic Kidney Disease due to Type 2 Diabetes in China From 1990 to 2021: A Population‐Based Study

Yifei Wang iD, Shiya Gu, Zhixuan Xie, Zhiyong Xu, Wenfang He, Yexiang Chen, Juan Jin, Qiang He iD

Journal of Diabetes · 2025-04 · 17 (4)

DOI: 10.1111/1753-0407.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 23.04.2025. Verfasst von Yifei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Ha…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Cost of Illness. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang, Postdoctoral Fellowship Program of CPSF, Taizhou City Science and Technology Bureau Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study analyzes the trends in the burden of chronic kidney disease due to type 2 diabetes (CKD‐T2D) in China from 1990 to 2021, evaluates variations in risk factors, and projects the disease burden through 2036.

Method

Estimates of prevalence, incidence, mortality, and disability‐adjusted life years (DALYs) for CKD‐T2D were retrieved along with their 95% uncertainty intervals (UIs). Age‐period‐cohort analysis was used to assess burden trends from 1990 to 2021, identify risk factor population attributable fractions (PAFs), and project the burden through 2036.

Results

In 2021, there were 20 911 520 CKD‐T2D cases in China, with an age‐standardized prevalence rate (ASPR) of 1053.92 per 100 000, an incidence rate (ASIR) of 23.07, an age‐standardized mortality rate (ASMR) of 5.72, and an age‐standardized DALY rate (ASDR) of 122.15. Although the overall burden showed a slow decline from 1990 to 2021, incidence continued to rise. The 2021 data revealed a marked age effect, with the burden rising with age. Period effects also contributed to an increased risk, with metabolic risk factors such as high fasting plasma glucose and BMI contributing the most. Projections suggest a decline in mortality and DALYs by 2036, while incidence will keep increasing.

Conclusion

Despite declines in ASMR and ASDR, CKD‐T2D incidence and cases continue to rise, especially among males and the elderly. This increasing burden is driven by aging and metabolic risk factors. Early screening, education, and risk management are essential for addressing CKD‐T2D in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicCost of IllnessHumansChinaMaleFemaleMiddle AgedAgedIncidenceRisk FactorsAdultPrevalenceDisability-Adjusted Life YearsAged, 80 and overYoung Adult

Stichwörter der Autor:innen

Chinachronic kidney disease due to type 2 diabetes mellitusdisease burdenrisk factorstrends

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Hangzhou, Zhejiang, China.
  • Institute of Chronic Nephropathy, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Nephrology, XianJu People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Xianju, Zhejiang, China.
  • The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

ORCID-Profile: Yifei Wang, Qiang He

Förderung

  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang
  • Postdoctoral Fellowship Program of CPSF
  • Taizhou City Science and Technology Bureau Project
  • General Project of the Medical and Health of Zhejiang Province
  • Research Project of Zhejiang Chinese Medical University

Zitieren

APA

Wang, Y., Gu, S., Xie, Z., Xu, Z., He, W., Chen, Y., Jin, J., & He, Q. (2025). Trends and Disparities in the Burden of Chronic Kidney Disease due to Type 2 Diabetes in China From 1990 to 2021: A Population‐Based Study. Journal of Diabetes, 17(4). https://doi.org/10.1111/1753-0407.70084

Vancouver

Wang Y, Gu S, Xie Z, Xu Z, He W, Chen Y, et al. Trends and Disparities in the Burden of Chronic Kidney Disease due to Type 2 Diabetes in China From 1990 to 2021: A Population‐Based Study. Journal of Diabetes. 2025;17(4). doi:10.1111/1753-0407.70084

BibTeX
@article{Wang2025,
  author = {Wang, Yifei and Gu, Shiya and Xie, Zhixuan and Xu, Zhiyong and He, Wenfang and Chen, Yexiang and Jin, Juan and He, Qiang},
  title = {Trends and Disparities in the Burden of Chronic Kidney Disease due to Type 2 Diabetes in China From 1990 to 2021: A Population‐Based Study},
  journal = {Journal of Diabetes},
  year = {2025},
  volume = {17},
  number = {4},
  doi = {10.1111/1753-0407.70084}
}
Kostenlos starten →